论文部分内容阅读
作者报导了对18名皮下植入左旋18甲基炔诺酮(简称左旋18甲)妇女血清考的松水平测定的结果。参与研究的18名妇女年龄为20～32岁,月经规则,分娩1～6次,未哺乳,研究前至少一年未使用激素和宫内节育器,无慢性疾病及任何明显的内分泌疾病,于月经周期第0～4天在前臂皮下埋入6枚硅橡胶囊管(每枚内含左旋18甲34±2mg),于植入前及植入后1、6和12个月时连续二天于每天早上10～11点钟间取静脉血用放射免疫法测定血中考的松浓度。
The authors report the results of a serum test for 18 corticosteroids administered to 18 women who were subcutaneously injected with 18-norethisterone (L-18). The 18 women aged 20 to 32 years who participated in the study had regular menstruation with 1 to 6 deliveries, no breastfeeding, no use of hormones and IUDs at least one year prior to study, no chronic disease, and any overt endocrine disease. Menstrual cycle 0 to 4 days in the forearm subcutaneous embedded silicone rubber tube (each containing 18-L-18 ± 34mg) before implantation and 1, 6 and 12 months after implantation for two days in a row Venous blood was taken from 10 to 11 in the morning every morning to determine the concentration of cortisone in the blood by radioimmunoassay.